Arteris COO sells 13,448 shares in open-market trade

Arteris, Inc. Chief Operating Officer Laurent R. Moll executed an open-market sale of common stock.

Rhea-AI Filing Summary

Arteris, Inc. Chief Operating Officer Laurent R. Moll executed an open-market sale of common stock. On April 14, 2026, he sold 13,448 shares at a weighted average price of $20.0313 per share in multiple transactions.

After this sale, he directly holds 265,530 shares of Arteris common stock. The transaction was carried out under a Rule 10b5-1 trading plan that he adopted on March 12, 2026, indicating the sales were pre-scheduled rather than opportunistic. Individual trade prices ranged from $19.90 to $20.22 per share.

Insider Trade Summary 10b5-1

Net Seller: 13,448 shares

Net Sell 1 txn

Insider Moll Laurent R

Role Chief Operating Officer

Sold 13,448 shs ($269K)

Type	Security	Shares	Price	Value
Sale	Common Stock	13,448	$20.0313	$269K

Holdings After Transaction: Common Stock — 265,530 shares (Direct)

Footnotes (2)

1. F1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 12, 2026.
2. F2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.90 to $20.22 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold: 13,448 shares Weighted average sale price: $20.0313 per share Remaining holdings: 265,530 shares +3 more

6 metrics

Shares sold 13,448 shares Open-market sale on April 14, 2026

Weighted average sale price $20.0313 per share Average price for 13,448 shares sold

Remaining holdings 265,530 shares Shares directly held after the sale

Net shares sold 13,448 shares Net-sell direction in transaction summary

Sale price range $19.90 to $20.22 Range of individual trade prices on April 14, 2026

10b5-1 plan adoption date March 12, 2026 Date COO adopted trading plan used for this sale

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, open-market sale, transaction code "S"

4 terms

Rule 10b5-1 trading plan regulatory

"Transaction made pursuant to a 10b5-1 trading plan that was adopted..."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"The price reported in Column 4 is a weighted average sale price."

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

transaction code "S" regulatory

"transaction_code": "S","transaction_code_description":"Sale in open market"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Arteris (AIP) report for Laurent R. Moll?

Arteris reported that Chief Operating Officer Laurent R. Moll sold 13,448 shares of common stock in an open-market transaction. The sale occurred on April 14, 2026 at a weighted average price of $20.0313 per share, executed in multiple trades within a stated price range.

How many Arteris (AIP) shares does the COO hold after this Form 4 sale?

Following the reported sale, Chief Operating Officer Laurent R. Moll holds 265,530 shares of Arteris common stock directly. This figure reflects his position after selling 13,448 shares and helps investors gauge the scale of the transaction relative to his remaining ownership stake.

Was the Arteris (AIP) COO’s stock sale under a Rule 10b5-1 plan?

Yes. The filing notes the transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Laurent R. Moll on March 12, 2026. Such pre-arranged plans automatically schedule trades, reducing the likelihood that timing reflects short-term views on the stock.

At what prices did Laurent R. Moll’s Arteris (AIP) share sales occur?

The Form 4 reports a weighted average sale price of $20.0313 per share for Laurent R. Moll’s 13,448 sold shares. Individual trades took place in a range between $19.90 and $20.22 per share, all completed on April 14, 2026.

What type of transaction is disclosed in this Arteris (AIP) Form 4 filing?

The filing discloses an open-market sale of Arteris common stock by Chief Operating Officer Laurent R. Moll. It is categorized with transaction code “S,” which indicates a sale in the open market or a private transaction, rather than a grant, option exercise, or gift.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/16/2026 - 04:27 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Moll Laurent R

(Last) (First) (Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL CALIFORNIA 95008

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/14/2026		S(1)		13,448	D	$20.0313(2)	265,530	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 12, 2026.

2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.90 to $20.22 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Paul Alpern, as Attorney-in-Fact for Moll Laurent R	04/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)